KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Other Accumulated Expenses (2016 - 2025)

Merck (MRK) has disclosed Other Accumulated Expenses for 17 consecutive years, with $14.5 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 7.81% to $14.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $14.5 billion, a 7.81% decrease, with the full-year FY2025 number at $14.5 billion, down 7.81% from a year prior.
  • Other Accumulated Expenses was $14.5 billion for Q4 2025 at Merck, down from $16.2 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $16.5 billion in Q3 2024 to a low of $11.9 billion in Q1 2021.
  • A 5-year average of $14.3 billion and a median of $14.2 billion in 2021 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: rose 21.59% in 2021, then fell 9.43% in 2025.
  • Merck's Other Accumulated Expenses stood at $13.9 billion in 2021, then grew by 2.16% to $14.2 billion in 2022, then grew by 11.35% to $15.8 billion in 2023, then decreased by 0.46% to $15.7 billion in 2024, then fell by 7.81% to $14.5 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Other Accumulated Expenses are $14.5 billion (Q4 2025), $16.2 billion (Q3 2025), and $14.5 billion (Q2 2025).